Regeneron (REGN) is a publicly traded Healthcare sector company. As of August 16, 2026, REGN trades at $804.58 with a market cap of $82.72B and a P/E ratio of 19.20. REGN moved -0.30% today. Year to date, REGN is +4.10%; over the trailing twelve months it is +41.97%. Its 52-week range spans $476.49 to $821.11. Analyst consensus is buy with an average price target of $828.95. Rallies surfaces REGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for REGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $804.58 |
| Market Cap | $82.72B |
| P/E Ratio | 19.20 |
| EPS | $41.91 |
| Dividend Yield | 0.94% |
| 52-Week High | $821.11 |
| 52-Week Low | $476.49 |
| Volume | 281.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $15.53B |
| Net Income | $4.33B |
| Gross Margin | 0.00% |
21 analysts cover REGN: 0 strong buy, 14 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $828.95.